Host-pathogen interactions in sepsis

被引:391
作者
van der Poll, Tom [1 ,2 ]
Opal, Steven M. [3 ,4 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands
[2] Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands
[3] Mem Hosp, Div Infect Dis, Providence, RI USA
[4] Warren Alpert Brown Med Sch, Providence, RI USA
关键词
D O I
10.1016/S1473-3099(07)70265-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Sepsis is a major health problem. The concept that sepsis mortality is the result of an uncontrolled hyperinflammatory host response has recently been challenged. It is now widely thought that the host response to sepsis involves many, concomitant, integrated, and often antagonistic processes that involve both exaggerated inflammation and immune suppression. Several novel mediators and pathways have been shown to play a part. Moreover, evidence is accumulating that microbial virulence and bacterial load contribute to the host response and the outcome of severe infections. A complex and dynamic interaction exists between pathogens and host immune-defence mechanisms during the course of invasive infection. Some pathogens have acquired the capacity to communicate with each other and sense the host's vulnerabilities. Bidirectional signals are detectable at the critical interface between the host and microbial invaders. The outcome of this interaction determines the fate of the host at the outset of the septic process. A formidable array of innate and acquired immune defences must be breached if a pathogen is to successfully disseminate and cause severe sepsis and septic shock. This Review summarises current knowledge of microbial pathogenesis and host-pathogen interactions during sepsis and the ensuing development of potential therapeutics.
引用
收藏
页码:32 / 43
页数:12
相关论文
共 120 条
  • [1] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
    Abraham, E
    Reinhart, K
    Opal, S
    Demeyer, I
    Doig, C
    Rodriguez, AL
    Beale, R
    Svoboda, P
    Laterre, PF
    Simon, S
    Light, B
    Spapen, H
    Stone, J
    Seibert, A
    Peckelsen, C
    De Deyne, C
    Postier, R
    Pettilä, V
    Sprung, CL
    Artigas, A
    Percell, SR
    Shu, V
    Zwingelstein, C
    Tobias, J
    Poole, L
    Stolzenbach, JC
    Creasey, AA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 238 - 247
  • [2] Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
    Abraham, E
    Laterre, P
    Garg, R
    Levy, H
    Talwar, D
    Trzaskoma, BL
    Francois, B
    Guy, JS
    Bruckmann, M
    Rea-Neto, A
    Rossaint, R
    Perrotin, D
    Sablotzki, A
    Arkins, N
    Utterback, BG
    Macias, WL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) : 1332 - 1341
  • [3] Pathogen recognition and innate immunity
    Akira, S
    Uematsu, S
    Takeuchi, O
    [J]. CELL, 2006, 124 (04) : 783 - 801
  • [4] The impact of stress and nutrition on bacterial-host interactions at the intestinal epithelial surface
    Alverdy, J
    Zaborina, O
    Wu, LC
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (02) : 205 - 209
  • [5] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [6] Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia
    Aras, O
    Shet, A
    Bach, RR
    Hysjulien, JL
    Slungaard, A
    Hebbel, RP
    Escolar, G
    Jilma, B
    Key, NS
    [J]. BLOOD, 2004, 103 (12) : 4545 - 4553
  • [7] Small talk: Cell-to-cell communication in bacteria
    Bassler, BL
    [J]. CELL, 2002, 109 (04) : 421 - 424
  • [8] PapG-dependent adherence breaks mucosal inertia and triggers the innate host response
    Bergsten, G
    Samuelsson, M
    Wullt, B
    Leijonhufvud, I
    Fischer, H
    Svanborg, C
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (09) : 1734 - 1742
  • [9] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [10] Innate immune sensing and its roots: the story of endotoxin
    Beutler, B
    Rietschel, ET
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (02) : 169 - 176